MannKind Corp

21. aug 2026, 19:41 UTC

MannKind Corp. shares are lower today, trading near the lower end of their one-month range while above the 20-day moving average.

20. aug 2026, 19:51 UTC

MNKD lower today amid declines in the biotechnology sector.

19. aug 2026, 23:02 UTC

MannKind Corp shares are lower in after-market hours, continuing a downward trend amid broader declines in the biotechnology sector.

18. aug 2026, 22:51 UTC

MannKind Corp shares are lower in after-market hours, with no specific news identified. Broader market sentiment is impacted by rising sovereign bond yields.

17. aug 2026, 19:46 UTC

HC Wainwright lowered Q3 2026 EPS estimates for MannKind Corp to -$0.10 but maintained a “Buy” rating. Shares are higher since Friday's close.

14. aug 2026, 19:56 UTC

MannKind Corp. shares are higher today, reversing a four-session decline despite a broader market influenced by a drop in U.S. retail sales.

13. aug 2026, 19:01 UTC

MannKind Corp's shares are lower Thursday, continuing a five-day decline amid mixed economic signals and no specific news identified to explain the drop.

12. aug 2026, 20:06 UTC

MannKind Corp shares are lower today, continuing a decline since Tuesday's close amid shifting U.S. Treasury yields and broader market uncertainties.

11. aug 2026, 23:46 UTC

MannKind shares are higher in after-market trading, reflecting a slight recovery amid a cautious market ahead of the upcoming consumer price index report.

10. aug 2026, 22:56 UTC

MannKind Corp shares are higher in after-market hours following Monday's close, though no specific news was identified to explain the price movement.

7. aug 2026, 23:01 UTC

MannKind Corp shares declined in after-market trading, reflecting notable weakness despite remaining above the 20-day moving average. No specific news was identified.

6. aug 2026, 22:01 UTC

MannKind Corp shares are lower in after-market trading, reflecting broader market weakness and trading below their 20-day moving average. No specific news was identified.

5. aug 2026, 23:02 UTC

MannKind Corp shares declined after-hours following a second-quarter earnings miss, despite reporting revenues of $109.4 million and FDA approvals for new products.

4. aug 2026, 23:26 UTC

MannKind Corp shares are lower in after-market hours, with no specific news identified to explain the price movement. Trading has remained within a narrow range.

3. aug 2026, 22:51 UTC

MannKind Corp shares are higher in after-market trading, reflecting momentum since Monday's close amid falling Brent crude oil prices and positive market sentiment.

31. juuli 2026, 23:56 UTC

MannKind Corp shares traded lower in after-market hours, retreating from earlier gains. The stock remains near the lower end of its one-month range.

30. juuli 2026, 18:41 UTC

Wells Fargo raised MannKind's price target to $14.00, contributing to positive momentum. The company also reported favorable Phase 1b study results today.

29. juuli 2026, 19:47 UTC

MannKind Corp reported positive results from its Phase 1b INFLO-1 study, but shares are trading lower amid broader market uncertainty ahead of the Fed's decision.

28. juuli 2026, 21:01 UTC

MannKind Corp will report its second quarter 2026 financial results on August 5, 2026. Shares are trading higher in after-market hours.

27. juuli 2026, 22:06 UTC

MannKind Corp shares are higher in after-market trading, despite earlier declines. No specific news was identified to explain the price movement.

24. juuli 2026, 21:01 UTC

MannKind Corp shares are rising in after-market trading following FDA approval of Furoscix ReadyFlow™ for treating edema in heart failure and chronic kidney disease.

23. juuli 2026, 10:36 UTC

MannKind Corp shares are higher in pre-market trading, continuing an upward trend since Wednesday, despite declines in the broader tech sector.

22. juuli 2026, 21:01 UTC

MannKind Corp shares are higher in after-market trading, reflecting a gain since Wednesday's close, despite remaining below the 20-day moving average.

21. juuli 2026, 22:11 UTC

MannKind Corp shares rose in after-market trading, reflecting a broader rebound in technology stocks and strong interest in semiconductor and AI investments.